E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

  • Law Blogs

Become a Fan

« Takeda Chem. Indus., Ltd. v. Mylan Labs., Inc. (Fed. Cir. 2008) | Main | Stanford Law School Announces Launch of Patent Litigation Database »

December 17, 2008

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451ca1469e20105367d4430970b

Listed below are links to weblogs that reference Science Article Should Help Allay Gene Patenting Fears:

Comments

But the article presupposes litigation as the only measure of determining the stifling nature of patents. Many threats of lawsuits, internal due diligence, settlements prior to lawsuits, and licensing deals that may potentially impede development are not captured by merely looking at SEQ ID NOs in filed law suits.

The comments to this entry are closed.

November 2014

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30